Staurosporine is a small molecule. Staurosporine is a broad spectrum protein kinase inhibitor with activities ranging from anti-fungal to anti-hypertensive. Staurosporine is a typical ATP-competitive kinase inhibitor that binds to many kinases with high affinity, but with little selectivity.
This report contains market size and forecasts of Staurosporine in global, including the following market information:
Global Staurosporine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Staurosporine Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Staurosporine companies in 2021 (%)
The global Staurosporine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Staurosporine include Merck, Cayman Chemical, Bio-Techne, Enzo Biochem, Abcam, APExBIO Technology, Adooq Bioscience, Cell Signaling Technology and StressMarq Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Staurosporine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Staurosporine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Staurosporine Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Staurosporine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Staurosporine Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Staurosporine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Staurosporine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Staurosporine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Staurosporine revenues share in global market, 2021 (%)
Key companies Staurosporine sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Staurosporine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Cayman Chemical
Bio-Techne
Enzo Biochem
Abcam
APExBIO Technology
Adooq Bioscience
Cell Signaling Technology
StressMarq Biosciences
Biorbyt
Santa Cruz Biotechnology
Focus Biomolecules
BioVision
Thermo Fisher Scientific
Cell Guidance Systems
Abbexa
MP Biomedicals
Hello Bio
Toronto Research Chemicals
STEMCELL Technologies
Selleck Chemicals
AG Scientific
BPS Bioscience